Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?

Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement for beta-lactoglobulin (Lacprodan® BLG-100)

Technology that is changing the future

DISPERSOME®️ PLATFORM
Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.

IMPROVING OUTCOMESBy increasing solubility and dissolution rate the Dispersome®️  platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.

COMPATIBLE TECHNOLOGY
Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.